Corporate Board Profile
Tech Score: 67/100
2 mention(s) identify CHRISTINE E. SEIDMAN, M.D. as having software/technology expertise.
| Company | Filing Date | Evidence | Reason |
|---|---|---|---|
| Merck & Co., Inc. | 2021-04-05 | Dr. Seidman has extensive scientific experience relevant to the biopharmaceutical industry, including being the Thomas W. Smith Professor of Medicine and Genetics. | Dr. Seidman has extensive scientific experience and leads a research laboratory that integrates clinical medicine and molecular technologies, indicating technical skills. |
| Merck & Co., Inc. | 2022-04-04 | Dr. Seidman has extensive scientific experience relevant to the biopharmaceutical industry. | Dr. Seidman has extensive scientific experience and leads a research laboratory that integrates clinical medicine and molecular technologies, indicating technical skills. |
| Filing Date | Source Excerpt |
|---|---|
| 2020-04-06 | Dr. Seidman has extensive scientific experience relevant to the biopharmaceutical industry. |
| 2021-04-05 | Dr. Seidman has extensive scientific experience relevant to the biopharmaceutical industry, including being the Thomas W. Smith Professor of Medicine and Genetics. |
| 2022-04-04 | Dr. Seidman has extensive scientific experience relevant to the biopharmaceutical industry. |
Data sourced from SEC filings. Last updated: 2025-07-01